What Is an ERCP? Why It's Done, What to Expect, and the Known Risks
ERCP combines endoscopy and X-rays to treat bile and pancreatic duct problems. Learn why it is done, what to expect, the known risks, and warning signs.
Plain-language articles on Olympus duodenoscopes and endoscopes, scope-related infections, FDA actions, and the legal process.
ERCP combines endoscopy and X-rays to treat bile and pancreatic duct problems. Learn why it is done, what to expect, the known risks, and warning signs.
Where the Olympus scope infection litigation stands in November 2026: the courts, the FDA's import alert and warning letter, and what to watch next.
Plain answers to common questions about Olympus scope infection lawsuits: which devices are involved, what is alleged, what the FDA has done, and time limits.
In 2017 a Seattle jury sided with Olympus on design but found its warnings inadequate. Here is what that mixed verdict decided, and what it did not.
The FDA added five Olympus models to its import alert on October 20, 2026. Here is what the alert covers, what it does not, and what providers were told.
The FDA's October 7, 2026 warning letter cites quality-system violations at six Olympus facilities. Here is what it says, what it does not, and what comes next.
FDA safety communications explain why ERCP duodenoscopes can retain bacteria after cleaning. Here is what the agency has said, in plain language.